Skip to main content
Top
Published in: Calcified Tissue International 4/2015

01-04-2015 | Original Research

First Report of a Novel Missense CLDN19 Mutations Causing Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in a Chinese Family

Authors: Tao Yuan, Qianqian Pang, Xiaoping Xing, Xi Wang, Yuhui Li, Jingjun Li, Xueyan Wu, Mei Li, Ou Wang, Yan Jiang, Jin Dong, Weibo Xia

Published in: Calcified Tissue International | Issue 4/2015

Login to get access

Abstract

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive disorder caused by mutations in the CLDN16 or CLDN19 genes, encoding claudin-16 and claudin-19 in the thick ascending limb of Henle’s loop. In patients with claudin-19 mutations, severe ocular involvement (macular coloboma, pigmentary retinitis, nystagmus, or visual loss) has been described. In this report, we presented a 12-year-old girl with rickets, polyuria, and polydipsia. She was the daughter of consanguineous parents, and she had a history of recurred hypocalcemic and hypomagnesemic tetany. On physical examination, bilateral horizontal nystagmus and severe myopia were detected. Laboratory examination revealed hypomagnesemia, hypocalcemia, hypercalciuria, nephrocalcinosis, and renal stone. A clinical diagnosis of FHHNC caused possibly by claudin-19 mutation was decided with the ocular findings. DNA analysis revealed a novel homozygous missense mutation c.241C>T in the CLDN19 gene. In conclusion, in a patient with hypomagnesemia, hypercalciuria, nephrocalcinosis, and ocular findings, a diagnosis of FHHNC caused by claudin-19 mutation should be considered. This is the first study of FHHNC in Chinese population. Our findings of the novel mutation c.241C>T in exon 2 add to the list of more than 16 mutations of CLDN19 gene reported.
Literature
1.
go back to reference Michelis MF et al (1972) Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. (Evaluation of the pathophysiological role of parathyroid hormone). Metabolism 21(10):905–920CrossRefPubMed Michelis MF et al (1972) Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. (Evaluation of the pathophysiological role of parathyroid hormone). Metabolism 21(10):905–920CrossRefPubMed
2.
go back to reference Weber S et al (2000) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 8(6):414–422CrossRefPubMed Weber S et al (2000) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 8(6):414–422CrossRefPubMed
3.
go back to reference Muller D, Kausalya PJ, Bockenhauer D, Thumfart J, Meij IC, Dillon MJ, Van’T HW, Hunziker W (2006) Unusual clinical presentation and possible rescue of a novel claudin-16 mutation. J Clin Endocrinol Metab 91:3076–3079CrossRefPubMed Muller D, Kausalya PJ, Bockenhauer D, Thumfart J, Meij IC, Dillon MJ, Van’T HW, Hunziker W (2006) Unusual clinical presentation and possible rescue of a novel claudin-16 mutation. J Clin Endocrinol Metab 91:3076–3079CrossRefPubMed
4.
go back to reference Simon DB et al (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2 + resorption. Science 285(5424):103–106CrossRefPubMed Simon DB et al (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2 + resorption. Science 285(5424):103–106CrossRefPubMed
5.
go back to reference Konrad M et al (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79(5):949–957CrossRefPubMedCentralPubMed Konrad M et al (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79(5):949–957CrossRefPubMedCentralPubMed
6.
go back to reference Haisch L et al (2011) The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder. Am J Kidney Dis 57(2):320–330CrossRefPubMed Haisch L et al (2011) The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder. Am J Kidney Dis 57(2):320–330CrossRefPubMed
7.
go back to reference Schlingmann KP, Konrad M, Seyberth HW (2004) Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol 19(1):13–25CrossRefPubMed Schlingmann KP, Konrad M, Seyberth HW (2004) Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol 19(1):13–25CrossRefPubMed
9.
go back to reference Godron A et al (2012) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol 7(5):801–809CrossRefPubMedCentralPubMed Godron A et al (2012) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol 7(5):801–809CrossRefPubMedCentralPubMed
10.
go back to reference Faguer S, Chauveau D, Cintas P, Tack I, Cointault O, Rostaing L, Vargas-Poussou R, Ribes D (2011) Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations. Clin J Am Soc Nephrol 6:355–360CrossRefPubMedCentralPubMed Faguer S, Chauveau D, Cintas P, Tack I, Cointault O, Rostaing L, Vargas-Poussou R, Ribes D (2011) Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations. Clin J Am Soc Nephrol 6:355–360CrossRefPubMedCentralPubMed
11.
go back to reference Claverie-Martin F, Garcia-Nieto V, Loris C, Ariceta G, Nadal I, Espinosa L, Fernandez-Maseda A, Anton-Gamero M, Avila A, Madrid A, Gonzalez-Acosta H, Cordoba-Lanus E, Santos F, Gil-Calvo M, Espino M, Garcia-Martinez E, Sanchez A, Muley R (2013) Claudin-19 mutations and clinical phenotype in spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 8:e53151CrossRefPubMedCentralPubMed Claverie-Martin F, Garcia-Nieto V, Loris C, Ariceta G, Nadal I, Espinosa L, Fernandez-Maseda A, Anton-Gamero M, Avila A, Madrid A, Gonzalez-Acosta H, Cordoba-Lanus E, Santos F, Gil-Calvo M, Espino M, Garcia-Martinez E, Sanchez A, Muley R (2013) Claudin-19 mutations and clinical phenotype in spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 8:e53151CrossRefPubMedCentralPubMed
12.
go back to reference Al-Shibli A, Konrad M, Altay W, Al MO, Al-Gazali L, Al AI (2013) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene. Saudi J Kidney Dis Transpl 24:338–344CrossRefPubMed Al-Shibli A, Konrad M, Altay W, Al MO, Al-Gazali L, Al AI (2013) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene. Saudi J Kidney Dis Transpl 24:338–344CrossRefPubMed
13.
go back to reference Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA (2008) Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118:619–628PubMedCentralPubMed Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA (2008) Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118:619–628PubMedCentralPubMed
14.
go back to reference Naeem M, Hussain S, Akhtar N (2011) Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease. Am J Nephrol 34:241–248CrossRefPubMed Naeem M, Hussain S, Akhtar N (2011) Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease. Am J Nephrol 34:241–248CrossRefPubMed
15.
go back to reference Terry S, Nie M, Matter K, Balda MS (2010) Rho signaling and tight junction functions. Physiology (Bethesda) 25:16–26CrossRef Terry S, Nie M, Matter K, Balda MS (2010) Rho signaling and tight junction functions. Physiology (Bethesda) 25:16–26CrossRef
16.
go back to reference Heiskala M, Peterson PA, Yang Y (2001) The roles of claudin superfamily proteins in paracellular transport. Traffic 2:93–98CrossRefPubMed Heiskala M, Peterson PA, Yang Y (2001) The roles of claudin superfamily proteins in paracellular transport. Traffic 2:93–98CrossRefPubMed
17.
go back to reference Vargas-Poussou R et al (2008) Report of a family with two different hereditary diseases leading to early nephrocalcinosis. Pediatr Nephrol 23(1):149–153CrossRefPubMed Vargas-Poussou R et al (2008) Report of a family with two different hereditary diseases leading to early nephrocalcinosis. Pediatr Nephrol 23(1):149–153CrossRefPubMed
18.
go back to reference Kasapkara CS et al (2011) A novel mutation of the claudin 16 gene in familial hypomagnesemia with hypercalciuria and nephrocalcinosis mimicking rickets. Genet Couns 22(2):187–192PubMed Kasapkara CS et al (2011) A novel mutation of the claudin 16 gene in familial hypomagnesemia with hypercalciuria and nephrocalcinosis mimicking rickets. Genet Couns 22(2):187–192PubMed
19.
go back to reference Kari JA, Farouq M, Alshaya HO (2003) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol 18(6):506–510PubMed Kari JA, Farouq M, Alshaya HO (2003) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol 18(6):506–510PubMed
20.
go back to reference Rodriguez-Soriano J, Vallo A (1994) Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria. Pediatr Nephrol 8:431–435CrossRefPubMed Rodriguez-Soriano J, Vallo A (1994) Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria. Pediatr Nephrol 8:431–435CrossRefPubMed
21.
go back to reference Knoers NV (2009) Inherited forms of renal hypomag nesemia: an update. Pediatr Nephrol 24(4):697–705CrossRefPubMed Knoers NV (2009) Inherited forms of renal hypomag nesemia: an update. Pediatr Nephrol 24(4):697–705CrossRefPubMed
22.
go back to reference Konrad M et al (2008) CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 19(1):171–181CrossRefPubMedCentralPubMed Konrad M et al (2008) CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 19(1):171–181CrossRefPubMedCentralPubMed
23.
go back to reference Zimmermann B et al (2006) Hydrochlorothiazide in CLDN16 mutation. Nephrol Dial Transpl 21(8):2127–2132CrossRef Zimmermann B et al (2006) Hydrochlorothiazide in CLDN16 mutation. Nephrol Dial Transpl 21(8):2127–2132CrossRef
24.
go back to reference Nijenhuis T et al (2005) Enhanced passive Ca2 + reabsorption and reduced Mg2 + channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115(6):1651–1658CrossRefPubMedCentralPubMed Nijenhuis T et al (2005) Enhanced passive Ca2 + reabsorption and reduced Mg2 + channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115(6):1651–1658CrossRefPubMedCentralPubMed
Metadata
Title
First Report of a Novel Missense CLDN19 Mutations Causing Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in a Chinese Family
Authors
Tao Yuan
Qianqian Pang
Xiaoping Xing
Xi Wang
Yuhui Li
Jingjun Li
Xueyan Wu
Mei Li
Ou Wang
Yan Jiang
Jin Dong
Weibo Xia
Publication date
01-04-2015
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-014-9951-7

Other articles of this Issue 4/2015

Calcified Tissue International 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.